Monitor vote outcome for reverse split authorization, which could signal management's intent to regain Nasdaq compliance. No immediate trading catalyst; wait for definitive proxy statement for more details.
Price Chart
Executive Summary
CytoSorbents filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting, soliciting votes on director elections, say-on-pay, auditor ratification, a reverse stock split authorization (1:5 to 1:20), and adjournment. The filing is routine and contains no financial disclosures.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for August 13, 2026, voting deadline August 12, 2026.
- Board recommends FOR all six proposals including reverse stock split (1:5 to 1:20) and director election.
- Proposal 4 authorizes board to effect reverse split at its discretion within one year of approval.
- No financial data or material business updates provided in the filing.
Financial Impact
No financial figures disclosed; potential dilutive effect of reverse split not determinable.
Risk Factors
- Reverse split may dilute shareholder value if not accompanied by fundamental improvement.
- Low market cap ($29M) and weak analyst consensus (0% bullish) indicate ongoing challenges.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-077803 |
| Document: 0001104659-26-077803-index-headers.html | 0001104659-26-077803 |
| Document: 0001104659-26-077803-index.html | 0001104659-26-077803 |
| Document: 0001104659-26-077803.txt | 0001104659-26-077803 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 8-K | $4.91 $5.35 | ▲ +8.96% | ▲ +8.27% | $4.85 (−1.22%) |
Aug 6, 2026 11w ago | Press Release | $0.3600 $0.3501 | ▲ +2.75% | ▲ +2.35% | $4.85 (−1247.22%) |
Jun 25, 2026 17w ago | DEFA14A | $0.3620 $0.3600 | ▼ −0.55% | ▼ −1.94% | $4.85 (+1239.78%) |
Jun 16, 2026 19w ago | Insider Cluster | $0.5189 $0.3694 | ▼ −28.81% | ▼ −28.86% | $4.85 (+834.67%) |
Apr 15, 2026 27w ago | 10-K/A | $0.6100 $0.5710 | ▼ −6.39% | ▼ −12.21% | $4.85 (+695.08%) |
Apr 2, 2026 29w ago | 8-K | $0.5830 $0.6100 | ▼ −4.63% | ▲ +5.25% | $4.85 (−731.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers